CN1210267A - Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity - Google Patents
Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity Download PDFInfo
- Publication number
- CN1210267A CN1210267A CN 97116236 CN97116236A CN1210267A CN 1210267 A CN1210267 A CN 1210267A CN 97116236 CN97116236 CN 97116236 CN 97116236 A CN97116236 A CN 97116236A CN 1210267 A CN1210267 A CN 1210267A
- Authority
- CN
- China
- Prior art keywords
- pregnancy
- plasma protein
- antibody
- kit
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A reagent box for quantitativel enzyme-linked test of plasma protein A associated with pregnancy comprises box body, coated reaction board with antigen concentration of 1mg/ml and dual diffusion titer higher than 1 : 32, standard reagents including freeze dried plasma protein A associated with pregnancy with purity higher than 95%, quality-controlled serum with same components as standard one and enzyme-labelled antigen with protein content of 0.2-1.5 mg/ml, and other auxiliary reagents. Its advantages include reasonable contained substances, stable performance, correct test and convenient application.
Description
The present invention relates to the kit of a kind of kit of determining plasma protein A related to pregnancy by enzyme combination quantity, particularly a kind of determining plasma protein A related to pregnancy by enzyme combination quantity.
Abnormal fetus is fetus, newborn child's illness and dead major reason, is to influence the key factor that population quality improves, and for reducing the birth of abnormal fetus to greatest extent, should carry out pre-natal diagnosis to fetus as early as possible.At present, methods for prenatal diagnosis is more, for example: female blood AFP pH-value determination pH, B ultrasonic etc., though B ultrasonic is diagnosed safety, no wound, the kind that diagnoses the illness is limited.Immediate development a kind of diagnostic method that utilizes the pregnant albumen Prenatal Screening abnormal fetus in pregnant woman's blood, the foundation of this method is: PAPP-A (PAPP-A) content is with stablizing increase pregnant age, PAPP-A is a kind of big molecular saccharides albumen by the secretion of placenta syneytiotrophoblast, this property of protein is stable, detect the PAPP-A level and can be directly acquainted with the placenta situation, reflect the fetal in utero growth indirectly.
The kit that the purpose of this invention is to provide a kind of determining plasma protein A related to pregnancy by enzyme combination quantity (PAPP-A), reagent stable performance in this kit, assembly is reasonable, is suitable for, and detects accurately, and is easy to use.
For achieving the above object, the present invention takes following design proposal: the kit of this determining plasma protein A related to pregnancy by enzyme combination quantity comprises: the kit box body, place bag in the box body by reaction plate and the packaged reagent of difference, reagent has: standard items, quality controlled serum, enzyme labelled antibody, and their composition is respectively:
Standard items: the freeze-dried powder of pregnancy-associated plasma protein-A, its purity are 〉=95%,
Quality controlled serum: the freeze-dried powder of pregnancy-associated plasma protein-A, its purity are 〉=95%,
Enzyme labelled antibody: with the antibody of the crosslinked anti-pregnancy-associated plasma protein-A of rabbit of horseradish peroxidase, its protein content 0.2-1.5mg/ml,
Bag is by reaction plate: the antibody that is used to wrap quilt is the antibody of the anti-pregnancy-associated plasma protein-A of rabbit, antibody concentration 1mg/ml, and double diffusion tires>and 1: 32.
Kit comprises mentioned reagent and bag at least by outside the reaction plate, for convenience, and also can pack into concentrated cleaner, developer A, developer B, stop buffer, sticker, semi-logarithmic scale paper etc.
Described concentrated cleaner is a phosphate buffer, and developer A is 1% tetramethyl benzidine (TMB), and developer B is a hydrogen peroxide, and stop buffer is a 1M sulfuric acid.
The purity of above-mentioned pregnancy-associated plasma protein-A (PAPP-A) is very high, can make the user more reliable as the typical curve of data basis of reference, additional in this kit have a quality controlled serum lyophilized products, and whether successful it can make each sign that detects, in order to avoid the conclusion that work makes mistake.
One, the preparation of standard items:
1, collect serum: collect the pregnant woman's venous blood that was higher than for 30 weeks pregnant week, 3000 rev/mins centrifugal 20 minutes, get serum in container, put in-20 ℃ of refrigerators and preserve.
2, the purifying of pregnancy-associated plasma protein-A (PAPP-A):
1. saturated ammonium sulfate is slightly carried:
Because PAPP-A dissolves in the solution of saturated ammonium sulfate and serum composition (volume ratio that is serum and saturated ammonium sulfate is 2: 1), therefore, when in serum, adding saturated ammonium sulfate to above-mentioned concentration, the PAPP-A dissolving, other albumen are removed with precipitation form, add saturated ammonium sulfate solution in the supernatant behind the precipitation separation, when supernatant: during saturated ammonium sulfate=1: 1 (volume ratio), the PAPP-A precipitate and separate.
2. Sephadex G200 chromatography:
Chromatography is got the blood serum sample of 5% bed volume, sample concentration 6mg/ml, and application of sample is collected, and eluent is the Tris-Hcl damping fluid.Measure the OD value under each collection tube 280nm, the 260nm wavelength, calculate protein concentration.Through the SDS-PACE vertical slab electrophoresis, detect its purity, will have highly active PAPP-A and merge, concentrate with hollow fiber ultrafiltration membrane.
3. DEAE-Sephadex A-50 ion-exchange chromatography
Chromatography: sample size is 10% of a bed volume, and sample concentration is 5mg/ml,
With 0.03M PB is eluent, and Nacl concentration increases gradually from 0-0.9M, and the continuous gradient wash-out is collected the 3rd peak, through concentrating.
4. immune affinity absorption:
Adsorbent is CNBr-sepharose 4B, soaks and abundant swelling with diluted acid, makes itself and the coupling of anti-normal person's whole serum antibody protein, and above-mentioned immunosorbent is drained, and adds sample, reprints absorption, and reservation filtrate is washed till 0D with damping fluid with adsorbent
280<0.02.Adsorbent reactivation, standby.
5. purity is reached the PAPP-A freeze-drying more than 95%, and take out a part as quality controlled serum and freeze-drying, the weight of standard items generally is controlled at 0.5-2.5 μ g in every kit, and the weight of quality controlled serum dried frozen aquatic products is 0.3-1.0 μ g, and above-mentioned weight can be made secondary PAPP-A assay.
Two, the preparation of enzyme labelled antibody:
1, immune animal:
The rabbit of selecting about 2 kilograms stimulates animal with the injection of 5-10mg Bacille Calmette-Guerin earlier, after 7-10 days as immune animal, PAPP-A is made Fu Shi Freund's complete adjuvant antigen liquid, adopt the immunity for the first time of subcutaneous multiple spot, after 2 weeks, the subcutaneous immunity second time of groin, after 2 weeks, examination blood and survey are tired.
2, antiserum separates, and identifies and preservation:
After treating that immune serum is tired up, the way of the disposable bloodletting of kill animals is adopted in sero-fast collection, and rabbit can be adopted 70ml left and right sides whole blood.Sterile cryogenic, many centrifuging and taking serum of 5000g.
Immune serum is identified:
1. mensuration-the double immunodiffusion of antibody titer;
2. antibody content is measured-contrary single-phase SRID;
3. antibody specificity-immune purity and cross reactivity
3, purifying antibody and mark
1. purifying antibody: add saturated ammonium sulfate (SAS) in serum, the volume ratio of serum and saturated ammonium sulfate is 2: 1, makes antibody heavy fixed, centrifuging, and antibody purity reaches more than 95%,
2. antibody labeling:
Adopt the glutaraldehyde two step method horseradish peroxidase (HRP) to be marked on the PAPP-A antibody packing ,-20 ℃ of freezing preservations.
4, bag is by reaction plate
The PAPP-A antibody of above-mentioned purity is made into the NaHCO that concentration is 1mg/ml
3(PH=9.6) damping fluid, 100 μ l/well wrap by reaction plate, filter, and inferior daily confining liquid 100 μ l/well are in 37 ℃ of sealings 2 hours, freeze-drying, standby.
Kit quality standard: standard items S
10D450 〉=0.16; 10 parts of negative findingses detect errorless; The accuracy sample is measured CV<15% (batch variation), 2-8 ℃ of preservation; Linear r>0.98.
Advantage of the present invention: the assembly of this kit is reasonable, and stable performance is measured accurately, and is easy to use.
The using method of this kit:
1, the variable concentrations liquid of preparation standard items:
1. with 25 times (concentration is 0.1M during detection) of concentrated cleaning solutions dilution;
2. add cleaning fluid 700 μ l in the bottle of standard items, vibration evenly;
3. add 400 μ l cleaning fluids in other 4 clean containers, these 4 volumes are designated as S
1, S
2, S
3, S
4
4. from 2., get 200ul liquid and add S
4In the bottle;
5. from S
4Bottle is got 200ul to S
3In the bottle;
6. from S
3Bottle is got 200ul to S
2In the bottle;
7. from S
2Bottle is got 200ul to S
1In the bottle.
Except that the standard items of above-mentioned variable concentrations, also need add testing sample to bag and (be become different multiples with cleaning solution dilution on the reaction plate hole according to pregnant Zhou Butong, for example: the serum in pregnant woman 9-14 week is with 1: 20 times of dilution), bag included by the hole of reaction plate-and quality controlled serum, blank test use the hole, after relevant each hole adds above-mentioned various test solution, wash each hole, add enzyme labelled antibody subsequently, add developer A, developer B mixed liquor after the washing, add the stop buffer stopped reaction again, with the blank zeroing, in 450nm wavelength place colorimetric, write down each hole OD value with microplate reader.Measure the statistical procedures of numerical value, adopt method of percentiles, wherein the 5th and the 95th percentile is represented the lower limit and the upper limit of PAPP-A normal reference range respectively, and the 50th percentile is a median.
Claims (3)
1, a kind of kit of determining plasma protein A related to pregnancy by enzyme combination quantity, it is characterized in that it comprises: the kit box body, place bag in the box body by reaction plate and the packaged reagent of difference, reagent has: standard items, quality controlled serum, enzyme labelled antibody, and their composition is respectively:
Standard items: the freeze-dried powder of pregnancy-associated plasma protein-A, its purity are 〉=95%,
Quality controlled serum: the freeze-dried powder of pregnancy-associated plasma protein-A, its purity are 〉=95%,
Enzyme labelled antibody: with the antibody of the crosslinked anti-pregnancy-associated plasma protein-A of rabbit of horseradish peroxidase, its protein content 0.2-1.5mg/ml,
Bag is by reaction plate: the antibody that is used to wrap quilt is the antibody of the anti-pregnancy-associated plasma protein-A of rabbit, antibody concentration 1mg/ml, and double diffusion tires>and 1: 32.
2, the kit of determining plasma protein A related to pregnancy by enzyme combination quantity according to claim 1 is characterized in that: every box Packing Unit of described standard items is 0.5-2.5 μ g, and the every box Packing Unit of quality controlled serum is 0.3-1.0 μ g.
3, the kit of determining plasma protein A related to pregnancy by enzyme combination quantity according to claim 1 is characterized in that also including in the kit:
Concentrated cleaner: phosphate buffer;
Developer A: tetramethyl benzidine;
Developer B: hydrogen peroxide;
Stop buffer: 1M sulfuric acid;
Sticker;
Semi-logarithmic scale paper.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97116236 CN1210267A (en) | 1997-09-04 | 1997-09-04 | Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97116236 CN1210267A (en) | 1997-09-04 | 1997-09-04 | Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1210267A true CN1210267A (en) | 1999-03-10 |
Family
ID=5173714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 97116236 Pending CN1210267A (en) | 1997-09-04 | 1997-09-04 | Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1210267A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
-
1997
- 1997-09-04 CN CN 97116236 patent/CN1210267A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11747082B2 (en) | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weber et al. | �~ 1-Microglobulin (protein HC): Features of a promising indicator of proximal tubular dysfunction | |
US4399217A (en) | Process and a device for the determination of serum lipoproteins | |
CN108490166B (en) | Improved experiment buffer solution and application thereof | |
EP2357475B1 (en) | Method for measuring cystatin c in human body fluid | |
AU652598B2 (en) | Diagnostic method for detecting the rupture of fetal membranes and test kit employing the method | |
US5932480A (en) | Measurement method and kit for hemoglobin A1c | |
CN101738473A (en) | Treponema pallidum antibody diagnostic kit and preparation method thereof | |
CN102967704B (en) | Kit for combined detection of 6 diabetic antibodies | |
DK173095B1 (en) | Immunochemical method for determination of stable glycosylated hemoglobin and diagnostic system for use in this method, | |
JP4197393B2 (en) | Test method for IgA nephropathy | |
CN1210267A (en) | Reagent box for determining plasma protein A related to pregnancy by enzyme combination quantity | |
WO2012092708A1 (en) | Method and reagent device for determining anti-ra33 antibody igg | |
CN114994306B (en) | Application of protein PKNOX1 in preparation of reagent for diagnosing alcoholic cardiomyopathy and diagnostic kit | |
CN102368068B (en) | Kit for detecting chlamydia pneumoniae IgM antibody | |
EP0770875B1 (en) | Marker and reagent for diabetes mellitus and diabetes mellitus complication | |
CN101042399A (en) | Diabetes autoantibody immunoblotting reagent kit | |
Thompson | Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis | |
US4731336A (en) | Immunoassay for complement fragments | |
Goodger et al. | Babesia bovis (argentina): studies on the composition and location of antigen associated with infected erythrocytes | |
JP3298812B2 (en) | Method for measuring urinary trypsin inhibitor | |
McCormick et al. | Microtransferrinuria and microalbuminuria: enhanced immunoassay | |
CN110687285A (en) | Diagnostic kit and application of MAK16 in preparation of early diagnosis reagent for systemic lupus erythematosus | |
CN103308697A (en) | Kit used for detecting natural bispecific antibody resistant to HCV (hepatitis C virus) coded non-structural proteins NS3 and NS5 | |
CN114280300B (en) | Application of urine protein in diagnosis of metabolic liver disease | |
CN111378627B (en) | Monoclonal antibody of Golgi apparatus protein 73, kit and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |